These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The treatment and control of vancomycin resistant enterococci. Fraise AP J Antimicrob Chemother; 1996 Nov; 38(5):753-6. PubMed ID: 8961044 [No Abstract] [Full Text] [Related]
13. Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci. Woodford N Microb Drug Resist; 2001; 7(3):229-36. PubMed ID: 11759084 [TBL] [Abstract][Full Text] [Related]
14. Genotypic Characterization of Vancomycin-Resistant Enterococcus spp. In Tertiary Center, Iran. Shokouhi S; Darazam IA; Javadi A; Rouhani M; Ghasemnejad M Infect Disord Drug Targets; 2017; 17(2):90-94. PubMed ID: 28228089 [TBL] [Abstract][Full Text] [Related]
15. Comparative in vitro activity of oritavancin and other agents against vancomycin-susceptible and -resistant enterococci. Sweeney D; Stoneburner A; Shinabarger DL; Arhin FF; Belley A; Moeck G; Pillar CM J Antimicrob Chemother; 2017 Feb; 72(2):622-624. PubMed ID: 27856721 [No Abstract] [Full Text] [Related]
16. Accuracy of the VITEK 2 system to detect glycopeptide resistance in enterococci. van Den Braak N; Goessens W; van Belkum A; Verbrugh HA; Endtz HP J Clin Microbiol; 2001 Jan; 39(1):351-3. PubMed ID: 11136798 [TBL] [Abstract][Full Text] [Related]
19. Vancomycin-resistant enterococci: pervasive and persistent pathogens. Boyce JM Infect Control Hosp Epidemiol; 1995 Dec; 16(12):676-9. PubMed ID: 8683084 [No Abstract] [Full Text] [Related]
20. From the Centers for Disease Control and Prevention. Assessment of testing for and completeness of reporting of vancomycin-resistant enterococci--Connecticut, 1994. JAMA; 1996 May; 275(18):1397. PubMed ID: 8618356 [No Abstract] [Full Text] [Related] [Next] [New Search]